Search
This is concludes our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company, on the subjects of counterfeit drugs sold online, search engine advertising what’s needed from regulators to protect Web users. PSM: FDA is preparing to receive public remarks regarding the online promotion of medical products and adverse event reporting. What recommendations will you/have you given? GB:…
Read MoreThe Partnership for Safe Medicines (PSM) issued the following statement regarding the International Internet Week of Action, code named Operation Pangea II, intended to curb illegal actions involving medical products. PSM is a group of organizations and individuals dedicated to protecting consumers from counterfeit medicines.
Read MoreThis is part four of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 | Part 3 PSM: In your estimation, how many…
Read MoreThis is part three of our interview with Garth Bruen, co-founder of KnujOn, an internet compliance company. We talked to him about the KnujOn system, search engine advertising and what’s needed from regulatory bodies to protect Web users from counterfeit and substandard drug solicitations online. Read: Part 1 | Part 2 PSM: What steps have search engines like Google and…
Read MoreIt was a cringe-worthy moment for China when 600 000 counterfeit antimalarial tablets were intercepted by the Nigerian government in June. Produced and shipped from China, they bore an unexpected label: "Made in India." Even the fakes were being faked. It was a new low. Many things are faked in China —from Gucci sunglasses to iPhones. Drugs are no exception.…
Read MoreThis is part two of an interview with Garth Bruen, the co-founder of KnujOn, an internet compliance company, on the KnujOn system, search engine advertising and what’s needed from regulatory agencies to protect consumers from counterfeit medical products advertised online. Read part one of our interview. PSM: Have you noticed an uptick in the number of Web users receiving or…
Read MoreThe dangers of online pharmacies and unlicensed drug sellers are well documented. In fact, recent reports released by KnujOn, an internet compliance company, found that 80 to 90 percent of search engine-sponsored advertisements of online drug pharmacies violate federal and state laws, including selling substandard and counterfeit drugs to unsuspecting consumers. To make matters worse, a detailed study of online…
Read MoreAs my colleague Thomas Kubic recently noted, most supporters of drug importation have a faulty assumption that developed countries like Canada, Australia, Japan and the 27 members of the European Union (E.U.) are insulated from the global threat of counterfeit drugs. In the coming weeks, we will take a closer look at some of these so-called “safe” countries and illustrate why there is no such thing as a “safe” country when it comes to drug importation.
Read MoreIt is no longer possible to identify counterfeit medical products, including medications and devices, by simply checking packaging and labeling. Improvements in technology have made it cheaper and easier to produce fake packaging and labels, making it nearly impossible for consumers and authorities to detect counterfeits without conducting tests on the products themselves, as illustrated by the sale of over…
Read MoreMarv D. Shepherd, PhD From intellectual property violations to grave health risks, the Partnership for Safe Medicines (PSM) brings you the facts and figures regarding the harmful effects of counterfeit drugs. One of our most popular tools: the interactive map of counterfeit drug incidents. As a PSM member, the International Anticounterfeiting Coalition (IACC) understands the dangers of counterfeit drugs and…
Read More